CSIMarket
 

23andme Holding Co  (ME)
Other Ticker:  
 

23andme Holding Co's

Competitiveness


 

ME Sales vs. its Competitors Q4 2023







Revenue Growth Comparisons




Net Income Comparison




<<  ME Stock Performance Comparisons



*Market share is calculated based on total revenue.

  News about 23andme Holding Co Contracts

title suggestion:The Next Frontier of Personalized Healthcare: 23andMe Launches Genetic Reports on Common Cancers

23andMe Launches New Genetic Reports on Common Forms of Cancer23andMe, the leading direct-to-consumer genetic testing company, has taken a major step forward in personalized healthcare with the launch of new genetic reports on common forms of cancer. Customers can now gain deeper insight into their likelihood of developing breast, colorectal, and prostate cancer through these reports, which are based on polygenic risk scores (PRS) developed by 23andMe.The introduction of these new reports underscores 23andMe's commitment to providing individuals with valuable genetic information that can help them make more informed decisions about their health. By analyzing thousands of genetic markers linked to cancer risk...

Navigating the Genetic Highway: 23andMe's Pivot from Revenue Dips to R&D Investments in Cancer Therapies.


23andMe is Stepping Up its Targeted Cancer Therapies Despite Falling Revenue
The genetic testing and research company 23andMe, is expanding its Phase 1/2a clinical trial, 23ME-00610, by enrolling 30 additional patients with advanced neuroendocrine and ovarian cancer. The trial is studying the investigational antibody called CD200R1??a potential harbinger of innovative targeted cancer treatments.
This strategic decision comes at a crucial time when the American biotech firm's Q3 2023 revenues have paintively shrunk by 34.27%, however, it's noteworthy that this downturn aligns with the market scenario as the overall revenue of the company's competitive cohort has seen a similar, year-on-year drop...





Who are 23andme Holding Co's Competitors?





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com